A nanocarrier conjugated lipophilic thiobenzoate complex of rhenium-188 loaded in the core of a lipid nanocapsule, containing a CXCR4 function-blocking antibody named 12G5 (12G5-LNC188Re), was investigated by Séhédic and colleagues in an in vivo model of glioblastoma [132]. Here, CXCR4 is linked to glioblastoma.